Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Neoplasms 4Breast Neoplasms 3Prostatic Neoplasms 2Melanoma 2Healthy Participants 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumor 2cMET-dysregulated Advanced Solid Tumors 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Solid Tumor 1Neoplastic Cells, Circulating 1Liver Cirrhosis 1

Interventions

toripalimab 6Injections 4tislelizumab 3sintilimab 3pembrolizumab 3cediranib 3glumetinib 2apatinib 2PM 01183 2Midazolam 2Irinotecan 2Gemcitabine 2Drug Therapy 2Digoxin 2Bupropion 2talazoparib 1spartalizumab 1sonidegib 1sitravatinib 1serabelisib 1sapanisertib 1rucaparib 1repaglinide 1penpulimab 1palbociclib 1lenvatinib 1fluzoparib 1erdafitinib 1entrectinib 1dactolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Advanced Solid Tumor × Digoxin × Clear all
NCT04887194 2024-05-08

PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates

Mirati Therapeutics Inc.

Phase 1 Completed
40 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT04322552 2022-11-07

A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advanced Solid Tumor Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
18 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡